Close Menu

NEW YORK – Progentec Diagnostics said on Wednesday it has completed a Series A financing round, raising $5 million.

The financing was led by Plains Venture Partners, the Oklahoma Seed Capital Fund, and the Oklahoma Angel Capital Fund II, managed by ni2E Management Company. Also participating in the round were NMC Health, OCA Ventures, Stanford University, the Oklahoma Medical Research Foundation, Mayo Clinic, and Burns & Stowers Investments.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.